Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $760,802 - $910,842
-6,200 Reduced 39.74%
9,400 $1.34 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $1.42 Million - $3.11 Million
15,600 New
15,600 $1.42 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Kopernik Global Investors, LLC Portfolio

Follow Kopernik Global Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kopernik Global Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kopernik Global Investors, LLC with notifications on news.